Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Fall on the Road
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
2023 Readersâ Choice Winners
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aclaris Therapts
(NQ:
ACRS
)
1.150
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
1.150
Bid (Size)
1.150 (13)
Ask (Size)
1.220 (3)
Prev. Close
1.150
Today's Range
1.150 - 1.150
52wk Range
0.5902 - 11.12
Shares Outstanding
70,925,042
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Biotech’s Role in Addressing the Pancreatic Cancer Emergency
March 14, 2024
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:NVX),(NASDAQ:IBRX),(NASDAQ:ACRS),(NYSE:NUVB) EQNX::TICKER_END
Via
FinancialNewsMedia
Lumen Technologies And 2 Other Stocks Under $2 Insiders Are Buying
March 06, 2024
The Dow Jones index closed lower by over 400 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Performance
YTD
+9.52%
+9.52%
1 Month
-4.96%
-4.96%
3 Month
+22.64%
+22.64%
6 Month
-84.52%
-84.52%
1 Year
-85.53%
-85.53%
More News
Read More
Aclaris Therapeutics: Q4 Earnings Insights
February 27, 2024
Via
Benzinga
Aclaris Therapeutics' ATI-1777 Faces Uphill Battle In Atopic Dermatitis Treatment Landscape, Analyst Downgrades
January 22, 2024
Via
Benzinga
The Analyst Landscape: 4 Takes On Aclaris Therapeutics
January 11, 2024
Via
Benzinga
Breaking Down Aclaris Therapeutics: 6 Analysts Share Their Views
December 18, 2023
Via
Benzinga
Aclaris Therapeutics Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
December 18, 2023
Via
Benzinga
Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 22, 2024
Via
Benzinga
Why Coherus BioSciences Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
January 22, 2024
Via
Benzinga
The Latest Analyst Ratings for Aclaris Therapeutics
November 14, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 16, 2024
Via
Benzinga
Why Is Dermatology Focused Aclaris Therapeutics Stock Trading Higher Today?
January 16, 2024
Via
Benzinga
Analyst Highlights Aclaris Therapeutics' Encouraging Efficacy For Eczema Candidate, But Cautions On Data Variations
January 10, 2024
Via
Benzinga
Crude Oil Falls 1%; Amarin Shares Spike Higher
January 10, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 10, 2024
Via
Benzinga
Nasdaq Gains 50 Points; US Crude Inventories Rise Last Week
January 10, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Aclaris Therapeutics Shares Fall On Mixed Results From Mid-Stage Eczema Trial
January 10, 2024
Via
Benzinga
Dow Surges 100 Points; PriceSmart Earnings Top Views
January 10, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 10, 2024
Via
Benzinga
Inflammatory Disease Focused Aclaris Therapeutics Reduces Staff After Failed Psoriatic Arthritis Study
December 20, 2023
Via
Benzinga
Why SentinelOne Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
December 06, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 05, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 14, 2023
Via
Benzinga
Crude Oil Gains Over 1%; US Budget Deficit Narrows For October
November 13, 2023
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.